Dr. Aliki Ntzifa is a postdoctoral researcher at the Analysis of Circulating Tumor Cells Laboratory (ACTC Lab), Department of Chemistry, National and Kapodistrian University of Athens, Greece. Her research focuses on Liquid Biopsy, specializing in the development and standardization of assays for analyzing circulating tumor cells and circulating tumor DNA in various cancers. During her Ph.D., she worked on detecting and characterizing CTCs, gene expression analysis, DNA mutations and methylation in NSCLC patients. As a postdoctoral researcher, she continues her work on liquid biopsy analysis and manages the quality management system and accreditation of the ACTC Lab based on ISO 15189 standards
Tuesday, 17 June 2025
Time |
Session |
|
13:30
14:15
|
-
Introduction
-
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer
-
Detection rate for ESR1 mutations is higher in CTC-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR
-
Questions and Answers
Auditorium 8
|